Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02360904 · ClinicalTrials.gov registry record · NA
A Yoga Program for Breast Cancer Patients Undergoing Chemotherapy
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02360904 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 50 participants.
The verdict
NCT02360904, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The primary aim of this study is to assess and compare change in QOL during chemotherapy as measured by the Functional Assessment of Cancer Therapy-Breast (FACT-Breast) score between patients receiving yoga and those not receiving yoga. Secondary endpoints will include other measures of QOL such as sleep quality measured with the Pittsburg Sleep Quality Inventory (PSQI), anxiety and depression using Hospital Anxiety and Depression Scale (HADS), and adherence to yoga and to chemotherapy treatment.
Interventions
- OTHER Yoga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-04 |
| Est. Completion | 2018-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02360904
The ClinicalTrials.gov registry entry for NCT02360904 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Yoga is the first listed.
NCT02360904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02360904 about?
NCT02360904 is a clinical study titled "A Yoga Program for Breast Cancer Patients Undergoing Chemotherapy". The primary aim of this study is to assess and compare change in QOL during chemotherapy as measured by the Functional Assessment of Cancer Therapy-Breast (FACT-Breast) score between patients receiving yoga and those not receiving yoga. Secondary endpoints will include other measures of QOL such as ...
What is the current status of trial NCT02360904?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2014-04. Estimated completion is 2018-12-05.
What interventions are being tested in trial NCT02360904?
The interventions under investigation include: Yoga (OTHER).
Who is sponsoring clinical trial NCT02360904?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.